Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 4,112 | 30,482 | 42,220 | 35,368 | 40,572 |
| Gross Profit | 4,112 | 30,482 | 42,220 | 35,368 | 40,572 |
| Operating Expenses | 115,221 | 124,573 | 125,863 | 111,604 | 74,856 |
| Operating Income | -111,109 | -94,091 | -83,643 | -76,236 | -34,284 |
| Interest Expense | 7,949 | 0 | 26 | 0 | 0 |
| Other Income | -1,752 | -707 | -4,537 | 2,496 | 3,083 |
| Pre-tax Income | -120,809 | -94,798 | -88,206 | -73,740 | -31,201 |
| Income Tax | -257 | 2,170 | N/A | N/A | -2,098 |
| Net Income Continuous | -120,552 | -96,968 | -88,206 | -73,740 | -29,103 |
| Minority Interests | -1,193 | N/A | N/A | N/A | 85 |
| Net Income | $-119,359 | $-96,968 | $-88,206 | $-73,740 | $-29,188 |
| EPS Basic Total Ops | -14.53 | -12.61 | -12.97 | -12.12 | -5.16 |
| EPS Basic Continuous Ops | -14.66 | -12.58 | -12.95 | -12.09 | -5.12 |
| EPS Diluted Total Ops | -14.53 | -12.61 | -13.09 | -12.12 | -5.28 |
| EPS Diluted Continuous Ops | -14.66 | -12.58 | -12.93 | -12.09 | -5.11 |
| EPS Diluted Before Non-Recurring Items | -13.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-105,590 | $-89,022 | $-79,854 | $-72,884 | $-32,017 |